AbbVie: Wins Accumulating While We Wait For Next BD Steps (NYSE:ABBV)

Group 1 - AbbVie has experienced strong performance recently, with a thriving commercial business and successful late-stage pipeline developments [2] - The legal team at AbbVie has secured long-term exclusivity for Rinvoq, enhancing its market position [2] Group 2 - The Growth Stock Forum offers a model portfolio of 15-20 stocks, a top picks list of up to 10 stocks expected to perform well, and trading ideas for both short-term and medium-term strategies [2]